Change of serum soluble CD14 level in newly diagnosed Type 2 diabetes and its significance

Hui MO,Shiping LIU,Zhiguang ZHOU,Weili TANG,Xiang YAN,Gan HUANG,Jianwei LI,Qiong FENG

DOI: https://doi.org/10.3969/j.issn.1672-7347.2010.07.009

2010-01-01

Abstract:Objective To determine the correlation of serum soluble CD14 (sCD14) level with the injury of vascular endothelial cells and chronic low grade inflammation in newly diagnosed Type 2 diabetes (T2 DM) . Methods ELISA was used to examine serum sCD 14 and serum soluble E-selectin (sE-selectin) level, while immunoturbidimetric assay was used to detect serum high sensi-tivity C reactive protein (hsCRP). Results The levels of serum sCD14, sE-selectin, and hsCRP in newly diagnosed T2DM group were higher than those in the euglycemic group [ sCD14 : (300.7 ± 136.6) ng/mL vs. (273. 3 ±86.0) ng/mL); sE-selectin: (21.3 ±7. 7) ng/mL vs. (32.9 ±11.4) ng/mL; hsCRP : (1.45 ±1.21) mg/L vs. (2.37 ±1.45)mg/L] , and there was a significant difference in the latter two parameters between the 2 groups ( P< 0. 01 ) . In the patients with newly diagnosed T2 DM , after matching blood pressure, blood sugar, and blood lipid, the levels of serum sCD14, sE-selectin, and hsCRP in the obese group were higher than those in the non-obese group. There was no significant difference in the former 2 parameters between the 2 groups. The serum sE-selectin was correlated with fasting blood sugar (r=0.369, P < 0.001), 2-hour postprandial blood sugar ( r = 0. 421, P < 0. 001 ) , glycosylated hemoglobin ( r =0. 291, P = O. 005 ), sCD14 (r = 0.312, P=0.002), and homeostasis model assessment - insulin resistance ( r = 0. 247, P =0.018) in the newly diagnosed T2DM group. Stepwise regression analysis showed that the serum sCD14 was one of the chief influencing factors on serum sE-selectin. Conclusion Serum sCD14 levels tend to increase in newly diagnosed T2DM patients, especially in the obese diabetic patients, which is one of the chief influencing factors to induce the injury of vascular endothelial cells. The innate immunity mediated by Toll-like receptor 4 may take part in the injury of vascular endothelial cells in newly diagnosed T2DM patients.